961 to 970 of 4,785 Results
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
JPEG Image - 514.0 KB -
MD5: 59f2b6552004989213a0f76ce25a30e3
Merisis Supercell glue kits (PRFM+ stem cell) and Fabrication steps of Supercell glue. A - Withdrawal of 9 ml of venous blood; B - Merisis stem cell tube; C blood transferred to stem cell tube; D – Centrifugation of stem cell tube; E - Stem cell tube after centrifugation; F - Asp... |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
JPEG Image - 265.9 KB -
MD5: a28557b38bcd078b822bc336e7305887
Mean PI, GI, PPD & CAL scores between different time intervals in control and test sites |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
JPEG Image - 234.1 KB -
MD5: b4e85a49a03bbf27e241725e166c32e6
Mean Defect Depth & Defect Fill scores between different time intervals in control and test sites |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
JPEG Image - 215.1 KB -
MD5: 3909f4d1fc10aeb5f677cd43d5bd9d76
EHI scores between control and test sites at 1 week |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
JPEG Image - 126.5 KB -
MD5: 8184166698063dd750f57a1dc2b8929b
Linear measurements on digitized images; 6A – Pre-operative measurements in control group; 6B – 3months post-operative measurements in control group; 6C – 6months post-operative measurements in control group; 6D - Pre-operative measurements in test group; 6E - 3months post-operat... |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
Plain Text - 3.7 KB -
MD5: 72d4f4f23885dbb35caf8b91875269b1
|
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
Tabular Data - 343 B - 5 Variables, 9 Observations - UNF:6:qJcR0zl7NPoMwT/8/XtPlw==
Age and Gender distribution among study subjects |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
Tabular Data - 1.6 KB - 16 Variables, 17 Observations - UNF:6:tKd7UePnuCkNGV2tgSt3Lg==
Comparison of mean clinical parameters between Control & Test sites at baseline, 3 Months & 6 Months period using Wilcoxon Signed Ranked Test |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
Tabular Data - 525 B - 9 Variables, 9 Observations - UNF:6:tVkMkuh236COgMWZVvRhIg==
Comparison of mean Defect Depth between different time intervals in control and test sites using Friedman's test followed by Wilcoxon Signed Rank Post hoc Analysis |
Jun 18, 2024 -
Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCS) in the management of intraosseous defects
Tabular Data - 210 B - 7 Variables, 4 Observations - UNF:6:3a9EXM2j+J+uCLW/HOOiHQ==
Comparison of EHI scores between control & test sites at 1 Week using McNemar's Test |